AWKNF AWAKN LIFE SCIENCES CORP

Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company is headquartered in Vancouver, Canada.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$1.58    OTCQB
As of 01/25/2022     OTCMarkets


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Unknown
Industry:  
Index country:  Canada
Country of incorporation:  
IPO date:  12/23/2021
Outstanding shares:  24,887,307
Average volume:  39,784
Market cap:   $42,806,168
Current dividend yield:  0.00%
Sedol:      
Valuation   (See tab for details)
PE ratio:   -13.77
PB ratio:   6.19
PS ratio:   0.00
Return on equity:   -175.06%
Net income %:   -37,828.79%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy